VEGF Receptor Signal Transduction
暂无分享,去创建一个
[1] R. Klein,et al. Excitatory Eph receptors and adhesive ephrin ligands. , 2001, Current opinion in cell biology.
[2] N. Ferrara,et al. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.
[3] L. Claesson‐Welsh,et al. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. , 2001, Experimental cell research.
[4] N. Ferrara. Vascular endothelial growth factor: molecular and biological aspects. , 1999, Current topics in microbiology and immunology.
[5] M. Shibuya,et al. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.
[6] A. Zeiher,et al. Phosphorylation of the endothelial nitric oxide synthase at Ser‐1177 is required for VEGF‐induced endothelial cell migration , 2000, FEBS letters.
[7] A. Adamis,et al. Vascular endothelial growth factor gene regulation and action in diabetic retinopathy. , 2002, Ophthalmology clinics of North America.
[8] V. Vincenti,et al. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). , 1999, Current topics in microbiology and immunology.
[9] S. Rafii,et al. Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.
[10] T. Sugimura,et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. , 1994, Cancer research.
[11] Seppo Ylä-Herttuala,et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 , 2001, Nature Medicine.
[12] L. Claesson‐Welsh,et al. Expression of protein tyrosine kinases in islet cells: possible role of the Flk-1 receptor for beta-cell maturation from duct cells. , 1994, Growth factors.
[13] D. Gomez,et al. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. , 1996, Cancer research.
[14] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[15] C. Pilarsky,et al. Differential gene expression by endothelial cells in distinct angiogenic states. , 2000, European journal of biochemistry.
[16] H. Cai,et al. Cloning and Characterization of Neuropilin-1-Interacting Protein: A PSD-95/Dlg/ZO-1 Domain-Containing Protein That Interacts with the Cytoplasmic Domain of Neuropilin-1 , 1999, The Journal of Neuroscience.
[17] M. Corada,et al. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). , 1996, The Journal of clinical investigation.
[18] K. Pajusola,et al. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. , 1993, Oncogene.
[19] K. Alitalo,et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. , 1998, Science.
[20] A. Luttun,et al. Placental Growth Factor (PlGF) and Its Receptor Flt‐1 (VEGFR‐1) , 2002 .
[21] M. Karkkainen,et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. , 2001, Cancer research.
[22] K. Kinzler,et al. Genes expressed in human tumor endothelium. , 2000, Science.
[23] K. Alitalo,et al. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. , 1994, Oncogene.
[24] K. Plate,et al. Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. , 1997, Cancer research.
[25] K. Alitalo,et al. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. , 1992, Cancer research.
[26] H. Kleinman,et al. Regulation of capillary formation by laminin and other components of the extracellular matrix. , 1997, EXS.
[27] S. Soker,et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. , 1992, The Journal of biological chemistry.
[28] T. Noda,et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. , 2001, Cancer research.
[29] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[30] M. Rocchi,et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. , 1996, Circulation.
[31] Roger Fan,et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90 , 1998, Nature.
[32] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[33] R. Jain,et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.
[34] S. Nishikawa,et al. Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3. , 2003, Blood.
[35] J. Peng,et al. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. , 1999, Development.
[36] K. Huang,et al. Signal transduction by VEGF receptor-1 wild type and mutant proteins. , 2001, Cellular signalling.
[37] R. Ganju,et al. Characterization of signal transduction pathways in human bone marrow endothelial cells. , 1997, Blood.
[38] K. Garcia,et al. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. , 2000, The Journal of biological chemistry.
[39] Jacques Landry,et al. Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase* , 2000, The Journal of Biological Chemistry.
[40] E. Ruoslahti,et al. Platelet-derived Growth Factor Receptor β and Vascular Endothelial Growth Factor Receptor 2 Bind to the β3Integrin through Its Extracellular Domain* , 2000, The Journal of Biological Chemistry.
[41] K. Shitara,et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells , 2000, Oncogene.
[42] Robert E. Ferrell,et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema , 2000, Nature Genetics.
[43] P. Carmeliet,et al. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.
[44] D. Hanahan,et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.
[45] K. Alitalo,et al. Vascular growth factors and lymphangiogenesis. , 2002, Physiological reviews.
[46] L. Mayo,et al. Utilization of Distinct Signaling Pathways by Receptors for Vascular Endothelial Cell Growth Factor and Other Mitogens in the Induction of Endothelial Cell Proliferation* , 2000, The Journal of Biological Chemistry.
[47] T. Yagi,et al. A requirement for neuropilin-1 in embryonic vessel formation. , 1999, Development.
[48] F. Peale,et al. Gene expression profiling in an in vitro model of angiogenesis. , 2000, The American journal of pathology.
[49] S. Shih,et al. Nonvascular role for vascular endothelial growth factor (VEGF): VEGFR‐1 and VEGFR‐2 activity is critical for neural retinal development , 2001 .
[50] G. Breier,et al. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. , 1999, Blood.
[51] J. Waltenberger,et al. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). , 1998, Biochemical and biophysical research communications.
[52] M. Sunday,et al. Differential expression of VEGF isoforms in mouse during development and in the adult , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.
[53] M. Goumans,et al. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. , 2000, The International journal of developmental biology.
[54] D. Gospodarowicz,et al. VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. , 1994, Growth factors.
[55] H Ueno,et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.
[56] L. Mayo,et al. Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation* , 2000, The Journal of Biological Chemistry.
[57] H. Granger,et al. Nitric Oxide Is an Upstream Signal of Vascular Endothelial Growth Factor-induced Extracellular Signal-regulated Kinase½ Activation in Postcapillary Endothelium* , 1998, The Journal of Biological Chemistry.
[58] B. Keyt,et al. Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors , 1996, The Journal of Biological Chemistry.
[59] K. Alitalo,et al. Vascular endothelial growth factor C induces angiogenesis in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[60] Steven A. Stacker,et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.
[61] G. Vrensen,et al. VEGFR‐3 in adult angiogenesis , 2001, The Journal of pathology.
[62] D. Birnbaum,et al. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. , 1993, Oncogene.
[63] Y. Satow,et al. Expression of the Vascular Endothelial Growth Factor ( VEGF ) Receptor Gene , KDR , in Hematopoietic Cells and Inhibitory Effect of VEGF on Apoptotic Cell Death Caused by Ionizing Radiation , 2022 .
[64] M. Marrero,et al. Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src* , 1999, The Journal of Biological Chemistry.
[65] K. Alitalo,et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. , 1999, American Journal of Pathology.
[66] M. Karkkainen,et al. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. , 2002, Seminars in cell & developmental biology.
[67] N. Ferrara. Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.
[68] T. Suda,et al. Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis. , 2001, Blood.
[69] R. Kalb,et al. Plexin-Neuropilin-1 Complexes Form Functional Semaphorin-3A Receptors , 1999, Cell.
[70] D. Gingras,et al. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins. , 2000, The Biochemical journal.
[71] J. Park,et al. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. , 1993, Molecular biology of the cell.
[72] J. Stone,et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.
[73] K. Hirschi,et al. Pericytes in the microvasculature. , 1996, Cardiovascular research.
[74] H. Dvorak,et al. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. , 1997, The Journal of investigative dermatology.
[75] A. Ullrich,et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.
[76] M. Shibuya,et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.
[77] L. Mayo,et al. VRAP Is an Adaptor Protein That Binds KDR, a Receptor for Vascular Endothelial Cell Growth Factor* , 2000, The Journal of Biological Chemistry.
[78] Zhong-ying Liu,et al. Characterization of Signal Transduction Pathways in Human Bone Marrow Endothelial Cells , 1997 .
[79] W. Risau,et al. Development and differentiation of endothelium. , 1998, Kidney international. Supplement.
[80] L. Aiello,et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. , 1996, The Journal of clinical investigation.
[81] G. Semenza,et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.
[82] P. Gerwins,et al. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. , 2000, Critical reviews in oncology/hematology.
[83] Melynda Boerm,et al. Mekk3 is essential for early embryonic cardiovascular development , 2000, Nature Genetics.
[84] E. Manseau,et al. Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis , 2002, The Journal of experimental medicine.
[85] N. Ferrara,et al. Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes , 1997, The Journal of Biological Chemistry.
[86] I. Zachary,et al. Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-delta and by mobilization of intracellular Ca2+. , 2001, The Biochemical journal.
[87] Michael Chopp,et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke , 2001, Nature Medicine.
[88] N. Copeland,et al. Mapping of the gene for vascular endothelial growth factor-D in mouse and man to the X chromosome. , 1997, Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology.
[89] A. Ullrich,et al. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. , 1993, Cancer research.
[90] D. Charnock-Jones,et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. , 1995, Journal of the National Cancer Institute.
[91] D. Donner,et al. Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma* , 1996, The Journal of Biological Chemistry.
[92] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[93] A. D. de Vos,et al. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[94] J. Balligand,et al. Hsp90 Ensures the Transition from the Early Ca2+-dependent to the Late Phosphorylation-dependent Activation of the Endothelial Nitric-oxide Synthase in Vascular Endothelial Growth Factor-exposed Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[95] N. Ferrara,et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism , 2002, Nature.
[96] H. Granger,et al. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. , 1998, American journal of physiology. Heart and circulatory physiology.
[97] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[98] R. Hehlmann,et al. HERV-K-T47D-Related long terminal repeats mediate polyadenylation of cellular transcripts. , 2000, Genomics.
[99] H. Granger,et al. Protein Kinase G Mediates Vascular Endothelial Growth Factor-induced Raf-1 Activation and Proliferation in Human Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[100] R. Kerbel,et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. , 1999, Biochemical and biophysical research communications.
[101] M. Goldberg,et al. Post-transcriptional Regulation of Vascular Endothelial Growth Factor by Hypoxia (*) , 1996, The Journal of Biological Chemistry.
[102] R Folberg,et al. Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.
[103] Yasuhiko Hayashi,et al. Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.
[104] B. J. Limberg,et al. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). , 2001, The Journal of biological chemistry.
[105] J. Winer,et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. , 1992, The Journal of biological chemistry.
[106] A. N. Corps,et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. , 1998, Biology of reproduction.
[107] G. Breier,et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.
[108] T. Kitsukawa,et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. , 1995, Development.
[109] K. Alitalo,et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[110] B. Terman,et al. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization , 1999, Oncogene.
[111] M. Blanar,et al. HCPTPA, a Protein Tyrosine Phosphatase That Regulates Vascular Endothelial Growth Factor Receptor-mediated Signal Transduction and Biological Activity* , 1999, The Journal of Biological Chemistry.
[112] H. Satoh,et al. Regional localization of the human c-ros-1 on 6q22 and flt on 13q12. , 1987, Japanese journal of cancer research : Gann.
[113] D. Connolly,et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.
[114] M A Moses,et al. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. , 1998, Stem cells.
[115] M. Karkkainen,et al. Insights into the Molecular Pathogenesis and Targeted Treatment of Lymphedema , 2002, Annals of the New York Academy of Sciences.
[116] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[117] C. Mailhos,et al. Vascular developmental biology: getting nervous. , 2000, Current opinion in genetics & development.
[118] I. Zachary,et al. Vascular Endothelial Growth Factor Stimulates Tyrosine Phosphorylation and Recruitment to New Focal Adhesions of Focal Adhesion Kinase and Paxillin in Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[119] M. Detmar,et al. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[120] E. Kremmer,et al. Mapping of the Sites for Ligand Binding and Receptor Dimerization at the Extracellular Domain of the Vascular Endothelial Growth Factor Receptor FLT-1* , 1997, The Journal of Biological Chemistry.
[121] G. Neufeld,et al. Neuropilin-2 and Neuropilin-1 Are Receptors for the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF) and of Placenta Growth Factor-2, but Only Neuropilin-2 Functions as a Receptor for the 145-Amino Acid Form of VEGF* , 2000, The Journal of Biological Chemistry.
[122] M. Karkkainen,et al. Overexpression of VEGF in Testis and Epididymis Causes Infertility in Transgenic Mice: Evidence for Nonendothelial Targets for VEGF , 1998, Journal of Cell Biology.
[123] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[124] V. Dixit,et al. Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[125] A. Palotie,et al. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. , 1996, Circulation.
[126] U. Ikeda,et al. Inhibition of vascular endothelial growth factor activity by transfection with the soluble FLT-1 gene. , 2000, Journal of cardiovascular pharmacology.
[127] W. Sessa,et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.
[128] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[129] T. Noda,et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[130] C. Frelin,et al. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. , 1993, Biochemical and biophysical research communications.
[131] K. Yamazaki,et al. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. , 1995, The Journal of clinical investigation.
[132] M. Shibuya,et al. A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain* , 1998, The Journal of Biological Chemistry.
[133] D. Mukhopadhyay,et al. Vascular Permeability Factor (VPF)/Vascular Endothelial Growth Factor (VEGF) Receptor-1 Down-modulates VPF/VEGF Receptor-2-mediated Endothelial Cell Proliferation, but Not Migration, through Phosphatidylinositol 3-Kinase-dependent Pathways* , 2001, The Journal of Biological Chemistry.
[134] N. Rahimi,et al. Receptor Chimeras Indicate That the Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Modulates Mitogenic Activity of VEGFR-2 in Endothelial Cells* , 2000, The Journal of Biological Chemistry.
[135] Weicheng Wu,et al. Sphingosine Kinase Mediates Vascular Endothelial Growth Factor-Induced Activation of Ras and Mitogen-Activated Protein Kinases , 2002, Molecular and Cellular Biology.
[136] P. Bohlen,et al. Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies* , 2000, The Journal of Biological Chemistry.
[137] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[138] M. Shibuya,et al. Neuropilin-1 Is a Placenta Growth Factor-2 Receptor* , 1998, The Journal of Biological Chemistry.
[139] W. Gerald,et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts , 1999, Nature.
[140] D. Charnock-Jones,et al. Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. , 1994, Biology of reproduction.
[141] M. Klagsbrun,et al. Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.
[142] G. Conn,et al. Purification and Characterization of a Naturally Occurring Vascular Endothelial Growth Factor · Placenta Growth Factor Heterodimer (*) , 1995, The Journal of Biological Chemistry.
[143] M. Shibuya,et al. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells , 1999, Oncogene.
[144] L. Williams,et al. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[145] J. Caro,et al. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. , 1994, Cellular & molecular biology research.
[146] T. Shirasawa,et al. Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. , 1995, Biochemical and biophysical research communications.
[147] A. Paetau,et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. , 1995, The American journal of pathology.
[148] R Bicknell,et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.
[149] Peter Carmeliet,et al. Molecular mechanisms of lymphangiogenesis in health and disease. , 2002, Cancer cell.
[150] H. Dvorak,et al. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.
[151] K. Shitara,et al. and surface marker for the lineage of monocyte-macrophages in humans Flt-1 , vascular endothelial growth factor receptor 1 , is a novel cell , 2001 .
[152] J. Waltenberger,et al. The Vascular Endothelial Growth Factor Receptor KDR Activates Multiple Signal Transduction Pathways in Porcine Aortic Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[153] R. Busse,et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.
[154] J. Winer,et al. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. , 1992, The Journal of clinical investigation.
[155] S. Ergün,et al. Vascular endothelial growth factor and its receptors in normal human testicular tissue , 1997, Molecular and Cellular Endocrinology.
[156] H. Phillips,et al. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. , 1993, Endocrinology.
[157] R. Linhardt,et al. Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. , 1997, Growth Factors.
[158] R. Soldi,et al. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2 , 1999, The EMBO journal.
[159] L Claesson-Welsh,et al. Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. , 2001, The international journal of biochemistry & cell biology.
[160] Jacques Landry,et al. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells , 1997, Oncogene.
[161] A Shinkai,et al. Mapping of the Sites Involved in Ligand Association and Dissociation at the Extracellular Domain of the Kinase Insert Domain-containing Receptor for Vascular Endothelial Growth Factor* , 1998, The Journal of Biological Chemistry.
[162] K. Alitalo,et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[163] C. Larsson,et al. Expression of the VEGF-related factor gene in pre- and postnatal mouse. , 1996, Biochemical and biophysical research communications.
[164] R. Klein,et al. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. , 2000, Molecular cell.
[165] H. Augustin,et al. A novel vascular endothelial growth factor encoded by Orf virus, VEGF‐E, mediates angiogenesis via signalling through VEGFR‐2 (KDR) but not VEGFR‐1 (Flt‐1) receptor tyrosine kinases , 1999, The EMBO journal.
[166] M. Waxham,et al. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites. , 1997, Biochemical and biophysical research communications.
[167] M. Shibuya,et al. The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma. , 1997, Biochemical and biophysical research communications.
[168] T. Veikkola,et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[169] G. Palade,et al. Neovasculature induced by vascular endothelial growth factor is fenestrated. , 1997, Cancer research.
[170] H. Dvorak,et al. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.
[171] M. Shibuya,et al. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). , 1994, Oncogene.
[172] C. Pritchard,et al. MEK kinase activity is not necessary for Raf‐1 function , 2001, The EMBO journal.
[173] S. Rafii,et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment , 2002, Nature Medicine.
[174] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[175] R. Soldi,et al. The angiogenesis induced by HIV–1 Tat protein is mediated by the Flk–1/KDR receptor on vascular endothelial cells , 1996, Nature Medicine.
[176] J. Waltenberger,et al. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. , 1999, Biochemical and biophysical research communications.
[177] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[178] M. Shibuya,et al. A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐γ and DNA synthesis in vascular endothelial cells , 2001, The EMBO journal.
[179] K. Plate,et al. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. , 1995, Cancer research.
[180] G. Neufeld,et al. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. , 2002, Trends in cardiovascular medicine.
[181] M. Karkkainen,et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. , 2002, Development.
[182] C. Cepko,et al. Flk-1, a Receptor for Vascular Endothelial Growth Factor (VEGF), Is Expressed by Retinal Progenitor Cells , 1996, The Journal of Neuroscience.
[183] Koichi Hattori,et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? , 2002, Nature Reviews Cancer.
[184] Napoleone Ferrara,et al. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. , 2002, Seminars in oncology.
[185] M. Wellner,et al. The Proliferative Effect of Vascular Endothelial Growth Factor Requires Protein Kinase C-α and Protein Kinase C-ζ , 1999 .
[186] S. Soker,et al. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[187] M. Goumans,et al. EGF , epithelium and Gene ablation and TGF β superfamily function in mice 253 Functional analysis of the TGF β receptor / Smad pathway through gene ablation in mice , 2000 .
[188] H. Dvorak,et al. Pathways of Macromolecular Extravasation Across Microvascular Endothelium in Response to VPF/VEGF and Other Vasoactive Mediators , 1999, Microcirculation.
[189] S. Soker,et al. Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[190] D. Y. Lee,et al. Vascular Endothelial Growth Factor Governs Endothelial Nitric-oxide Synthase Expression via a KDR/Flk-1 Receptor and a Protein Kinase C Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[191] J. Remacle,et al. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. , 2000, Biochimica et biophysica acta.
[192] J. Schlessinger. New Roles for Src Kinases in Control of Cell Survival and Angiogenesis , 2000, Cell.
[193] J. Staddon,et al. Vascular endothelial growth factor stimulates dephosphorylation of the catenins p120 and p100 in endothelial cells. , 2000, The Biochemical journal.
[194] Dian Feng,et al. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.
[195] B Z Levi,et al. VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells , 1995, The Journal of Biological Chemistry.
[196] G. Schatteman,et al. Angiogenesis: New insights and therapeutic potential , 2000, The Anatomical record.
[197] P. Huang,et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.
[198] M. Shibuya,et al. Structure and function of vascular endothelial growth factor receptor-1 and -2. , 1999, Current topics in microbiology and immunology.
[199] D. Dimitrov,et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. , 1992, Biochemical and biophysical research communications.
[200] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[201] B. Terman,et al. Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. , 1994, Biochemical and biophysical research communications.
[202] R. Ganju,et al. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. , 1997, Blood.
[203] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[204] Napoleone Ferrara,et al. Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.
[205] B. Olffson. Vascular endothelial grouth facter B, a novel growth facter for endothelial cells , 1996 .
[206] L. Orci,et al. Phorbol esters induce angiogenesis in vitro from large‐vessel endothelial cells , 1987, Journal of cellular physiology.
[207] G. Vrensen,et al. Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[208] N. Rahimi,et al. A role for cadherin-5 in regulation of vascular endothelial growth factor receptor 2 activity in endothelial cells. , 1999, Molecular biology of the cell.
[209] D. Mukhopadhyay,et al. Tyrosine Residues 951 and 1059 of Vascular Endothelial Growth Factor Receptor-2 (KDR) Are Essential for Vascular Permeability Factor/Vascular Endothelial Growth Factor-induced Endothelium Migration and Proliferation, Respectively* , 2001, The Journal of Biological Chemistry.
[210] J. Isner,et al. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. , 1999, The Journal of clinical investigation.
[211] B. Zetter,et al. Signaling Mechanisms in Growth Factor‐Stimulated Cell Motility , 1997, Stem cells.
[212] L. Orci,et al. Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis , 2001, The EMBO journal.
[213] K. Igarashi,et al. Sck interacts with KDR and Flt-1 via its SH2 domain. , 1998, Biochemical and biophysical research communications.
[214] J. Mudgett,et al. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[215] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[216] M. Shibuya,et al. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts , 1997, Oncogene.
[217] K. Alitalo,et al. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors , 1999, Cancer.
[218] H. Ueno,et al. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma. , 2000, Investigative ophthalmology & visual science.
[219] L. Claesson‐Welsh,et al. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.
[220] E C Nice,et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3 , 2001, The EMBO journal.
[221] K. Igarashi,et al. Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. , 1998, Biochemical and biophysical research communications.
[222] H. Granger,et al. Role of phospholipase C, protein kinase C, and calcium in VEGF-induced venular hyperpermeability. , 1999, The American journal of physiology.
[223] J. Bruder,et al. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. , 1999, Biochemical and biophysical research communications.
[224] Thomas Hawighorst,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.
[225] E. Manseau,et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. , 1993, Cancer research.
[226] T. Yagi,et al. Neuropilin–Semaphorin III/D-Mediated Chemorepulsive Signals Play a Crucial Role in Peripheral Nerve Projection in Mice , 1997, Neuron.
[227] B. Weinstein. What guides early embryonic blood vessel formation? , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.
[228] J. Folkman,et al. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. , 1996, The Journal of clinical investigation.
[229] A. Mercer,et al. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus , 1994, Journal of virology.
[230] Till Acker,et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.
[231] G. Thakker,et al. The Role of Phosphatidylinositol 3-Kinase in Vascular Endothelial Growth Factor Signaling* , 1999, The Journal of Biological Chemistry.
[232] K. Alitalo,et al. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. , 1999, Current topics in microbiology and immunology.
[233] M. Moses. The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors , 1997 .
[234] P. Carmeliet,et al. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. , 1999, Current topics in microbiology and immunology.
[235] M. Karkkainen,et al. Lymphatic endothelium: a new frontier of metastasis research , 2002, Nature Cell Biology.
[236] K. Alitalo,et al. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response , 1999, Oncogene.
[237] S. Nishikawa,et al. Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-Stimulating Factor in the Support of Osteoclastic Bone Resorption , 1999, The Journal of experimental medicine.
[238] E. Manseau,et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. , 1993, The American journal of pathology.
[239] R. Maciewicz,et al. Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis , 2000, Laboratory Investigation.
[240] K. Pumiglia,et al. Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation* , 2001, The Journal of Biological Chemistry.
[241] T. Pawson,et al. Signaling through scaffold, anchoring, and adaptor proteins. , 1997, Science.
[242] E. Wagner,et al. Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases , 1994, Current Biology.
[243] G. Breier,et al. The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.
[244] G. Breier,et al. Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.
[245] N. Ferrara,et al. A repressor sequence in the juxtamembrane domain of Flt‐1 (VEGFR‐1) constitutively inhibits vascular endothelial growth factor‐dependent phosphatidylinositol 3′‐kinase activation and endothelial cell migration , 2000, The EMBO journal.
[246] R. D. Rudic,et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. , 1998, The Journal of clinical investigation.
[247] U. Hellman,et al. Differential Binding of Vascular Endothelial Growth Factor B Splice and Proteolytic Isoforms to Neuropilin-1* , 1999, The Journal of Biological Chemistry.
[248] G. Kay,et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. , 2000, Circulation research.
[249] K. Alitalo,et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells , 1993, The Journal of experimental medicine.
[250] K. Alitalo,et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. , 2002, Journal of the National Cancer Institute.
[251] F. Fagotto,et al. The ins and outs of APC and β‐catenin nuclear transport , 2002 .
[252] Willem Flameng,et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 , 1999, Nature Medicine.
[253] M. Waxham,et al. Interaction of the Flt-1 Tyrosine Kinase Receptor with the p85 Subunit of Phosphatidylinositol 3-Kinase , 1995, The Journal of Biological Chemistry.
[254] Yihai Cao,et al. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1 , 1998, Oncogene.
[255] K. Alitalo,et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. , 1996, Development.
[256] J. Partanen,et al. FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. , 1992, Cancer research.
[257] A J Warner,et al. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells. , 2000, The Biochemical journal.
[258] B. J. Limberg,et al. Vascular Endothelial Growth Factor Receptor-2 and Neuropilin-1 Form a Receptor Complex That Is Responsible for the Differential Signaling Potency of VEGF165 and VEGF121 * , 2001, The Journal of Biological Chemistry.
[259] R. Eddy,et al. Identification of a new endothelial cell growth factor receptor tyrosine kinase. , 1991, Oncogene.
[260] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[261] C. Wernstedt,et al. Identification of Vascular Endothelial Growth Factor Receptor-1 Tyrosine Phosphorylation Sites and Binding of SH2 Domain-containing Molecules* , 1998, The Journal of Biological Chemistry.
[262] R K Jain,et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[263] G. Garcı́a-Cardeña,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.
[264] D. Birnbaum,et al. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. , 1995, Oncogene.
[265] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[266] S. Stacker,et al. Viral Vascular Endothelial Growth Factor Plays a Critical Role in Orf Virus Infection , 2000, Journal of Virology.
[267] J. Rossant,et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.
[268] K. Alitalo,et al. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. , 2000, Blood.
[269] N. Copeland,et al. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[270] Shakil Ahmad,et al. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review. , 2000, Placenta.
[271] P. Schwartzberg,et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.
[272] B. Keyt,et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. , 1996, Journal of cardiovascular pharmacology.
[273] R. D'Amato,et al. Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[274] B. Zetter,et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. , 1999, Microvascular research.
[275] J. Alexander,et al. Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.
[276] P. Brickell,et al. src‐related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells , 1994, FEBS letters.